Single-cell RNA sequencing reveals the impaired epidermal differentiation and pathological microenvironment in diabetic foot ulcer

Abstract

Background: Diabetic foot ulcer (DFU) is one of the most common and complex complications of diabetes, but the underlying pathophysiology remains unclear. Single-cell RNA sequencing (scRNA-seq) has been conducted to explore novel cell types or molecular profiles of DFU from various perspectives. This study aimed to comprehensively analyze the potential mechanisms underlying impaired re-epithelization of DFU in a single-cell perspective. Methods: We conducted scRNA-seq on tissues from human normal skin, acute wound, and DFU to investigate the potential mechanisms underlying impaired epidermal differentiation and the pathological microenvironment. Pseudo-time and lineage inference analyses revealed the distinct states and transition trajectories of epidermal cells under different conditions. Transcription factor analysis revealed the potential regulatory mechanism of key subtypes of keratinocytes. Cell–cell interaction analysis revealed the regulatory network between the proinflammatory microenvironment and epidermal cells. Laser-capture microscopy coupled with RNA sequencing (LCM-seq) and multiplex immunohistochemistry were used to validate the expression and location of key subtypes of keratinocytes. Results: Our research provided a comprehensive map of the phenotypic and dynamic changes that occur during epidermal differentiation, alongside the corresponding regulatory networks in DFU. Importantly, we identified two subtypes of keratinocytes: basal cells (BC-2) and diabetes-associated keratinocytes (DAK) that might play crucial roles in the impairment of epidermal homeostasis. BC-2 and DAK showed a marked increase in DFU, with an inactive state and insufficient motivation for epidermal differentiation. BC-2 was involved in the cellular response and apoptosis processes, with high expression of TXNIP, IFITM1, and IL1R2. Additionally, the pro-differentiation transcription factors were downregulated in BC-2 in DFU, indicating that the differentiation process might be inhibited in BC-2 in DFU. DAK was associated with cellular glucose homeostasis. Furthermore, increased CCL2+CXCL2+ fibroblasts, VWA1+ vascular endothelial cells, and GZMA+CD8+ T cells were detected in DFU. These changes in the wound microenvironment could regulate the fate of epidermal cells through the TNFSF12-TNFRSF12A, IFNG-IFNGR1/2, and IL-1B-IL1R2 pathways, which might result in persistent inflammation and impaired epidermal differentiation in DFU. Conclusions: Our findings offer novel insights into the pathophysiology of DFU and present potential therapeutic targets that could improve wound care and treatment outcomes for DFU patients.

Keywords

Diabetic foot ulcer / Re-epithelization / Wound microenvironment / Epidermal homeostasis / Single-cell RNA sequencing

References

[1] Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha FJD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-81. https://doi.org/10.1016/j.diabres.2018.02.023.

[2] Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017; 376: 2367-75. https://doi.org/10.1056/NEJMra1615439.

[3] Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018; 1411: 153-65. https://doi.org/10.1111/nyas.13569.

[4] Hart T, Milner R, Cifu A.Management of a Diabetic Foot. JAMA. 2017; 318: 1387-8. https://doi.org/10.1001/jama.2017.11700.

[5] Liu Y, Shi Y, Zhu J, Chen X, Yang R, Shu B, et al. Study on the effect of the five-in-one comprehensive limb salvage Technologies of Treating Severe Diabetic Foot. Adv Wound Care (New Rochelle). 2020; 9: 676-85. https://doi.org/10.1089/wound.2018.0903.

[6] Mauricio D, Jude E, Piaggesi A, Frykberg R. Diabetic foot: current status and future prospects. J Diabetes Res. 2016; 2016: 5691305-2. https://doi.org/10.1155/2016/5691305.

[7] Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol. 2015; 173: 370-8. https://doi.org/10.1111/bjd.13954.

[8] Davis FM, Kimball A, Boniakowski A, Gallagher K. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep. 2018; 18: 2. https://doi.org/10.1007/s11892-018-0970-z.

[9] Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev. 2019; 99: 665-706. https://doi.org/10.1152/physrev.00067.2017.

[10] Conte MI, Fuentes-Trillo A, Domínguez CC. Opportunities and tradeoffs in single-cell transcriptomic technologies. Trends Genet. 2024; 40: 83-93. https://doi.org/10.1016/j.tig.2023.10.003.

[11] Theocharidis G, Baltzis D, Roustit M, Tellechea A, Dangwal S, Khetani RS, et al. Integrated skin Transcriptomics and serum multiplex assays reveal novel mechanisms of wound healing in diabetic foot ulcers. Diabetes. 2020; 69: 2157- 69. https://doi.org/10.2337/db20-0188.

[12] Theocharidis G, Thomas BE, Sarkar D, Mumme HL, Pilcher WJR, Dwivedi B, et al. Single cell transcriptomic landscape of diabetic foot ulcers. Nat Commun. 2022; 13: 181. https://doi.org/10.1038/s41467-021-27801-8.

[13] Du H, Li S, Lu J, Tang L, Jiang X, He X, et al. Single-cell RNA-seq and bulk-seq identify RAB17 as a potential regulator of angiogenesis by human dermal microvascular endothelial cells in diabetic foot ulcers. Burns. Trauma. 2023; 11: tkad020. https://doi.org/10.1093/burnst/tkad020.

[14] Tellechea A, Bai S, Dangwal S, Theocharidis G, Nagai M, Koerner S, et al. Topical application of a mast cell stabilizer improves impaired diabetic wound healing. J Invest Dermatol. 2020; 140: 901-11. e11. https://doi.org/10.1016/j.jid.2019.08.449.

[15] Audu CO, Melvin WJ, Joshi AD, Wolf SJ, Moon JY, Davis FM, et al. Macrophage-specific inhibition of the histone demethylase JMJD3 decreases STING and pathologic inflammation in diabetic wound repair. Cell Mol Immunol. 2022; 19: 1251-62. https://doi.org/10.1038/s41423-022-00919-5.

[16] Haensel D, Jin S, Sun P, Cinco R, Dragan M, Nguyen Q, et al. Defining epidermal basal cell states during skin homeostasis and wound healing using single-cell Transcriptomics. Cell Rep. 2020; 30: 3932-47.e6. https://doi.org/10.1016/j.celrep.2020.02.091.

[17] Polito MP, Marini G, Palamenghi M, Enzo E. Decoding the human epidermal complexity at single-cell resolution. Int J Mol Sci. 2023; 24: 8544. https://doi.org/10.3390/ijms24108544.

[18] Wang S, Drummond ML, Guerrero-Juarez CF, Tarapore E, Maclean AL, Stabell AR, et al. Single cell transcriptomics of human epidermis identifies basal stem cell transition states. Nat Commun. 2020; 11: 4239. https://doi.org/10.1038/s41467-020-18075-7.

[19] Zou Z, Long X, Zhao Q, Zheng Y, Song M, Ma S, et al. A single-cell transcriptomic atlas of human skin aging. Dev Cell. 2021; 56: 383-97.e8. https://doi.org/10.1016/j.devcel.2020.11.002.

[20] Brady SP. Parakeratosis. J Am Acad Dermatol. 2004; 50: 77-84. https://doi.org/10.1016/s0190-9622(03)02801-9.

[21] Tsutsui K, Machida H, Nakagawa A, Ahn K, Morita R, Sekiguchi K, et al. Mapping the molecular and structural specialization of the skin basement membrane for inter-tissue interactions. Nat Commun. 2021; 12: 2577. https://doi.org/10.1038/s41467-021-22881-y.

[22] Zhang X, Yin M, Zhang LJ. Keratin 6, 16 and 17-critical barrier Alarmin molecules in skin wounds and psoriasis. Cells. 2019; 8: 8. https://doi.org/10.3390/cells8080807.

[23] Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009; 10: 207-17. https://doi.org/10.1038/nrm2636.

[24] Sarkar MK, Hile GA, Tsoi LC, Xing X, Liu J, Liang Y, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018; 77: 1653-64. https://doi.org/10.1136/annrheumdis-2018-213197.

[25] Shao S, Tsoi LC, Sarkar MK, Xing X, Xue K, Uppala R, et al. IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Sci Transl Med. 2019; 11: 7561. https://doi.org/10.1126/scitranslmed.aav7561.

[26] Finnegan A, Cho RJ, Luu A, Harirchian P, Lee J, Cheng JB, et al. Single-cell Transcriptomics reveals spatial and temporal turnover of keratinocyte differentiation regulators. Front Genet. 2019; 10: 775. https://doi.org/10.3389/fgene.2019.00775.

[27] Neph S, Stergachis AB, Reynolds A, Sandstrom R, Borenstein E, Stamatoyannopoulos JA. Circuitry and dynamics of human transcription factor regulatory networks. Cell. 2012; 150: 1274-86. https://doi.org/10.1016/j.cell.2012.04.040.

[28] Oberbeck N, Pham VC, Webster JD, Reja R, Huang CS, Zhang Y, et al. The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function. Nature. 2019; 574: 249-53. https://doi.org/10.1038/s41586-019-1615-3.

[29] Girousi E, Muerner L, Parisi L, Rihs S, Von Gunten S, Katsaros C, et al. Lack of IRF6 disrupts human epithelial homeostasis by altering Colony morphology, migration pattern, and differentiation potential of keratinocytes. Front Cell Dev Biol. 2021; 9: 718066. https://doi.org/10.3389/fcell.2021.718066.

[30] Chen R, Deng H, Zou L. Analysis of bulk transcriptome sequencing data and in vitro experiments reveal SIN3A as a potential target for diabetic foot ulcer. Diabetes Metab Syndr Obes. 2023;Volume 16: 4119-32. https://doi.org/10.2147/dmso.S439924.

[31] Bin L, Deng L, Yang H, Zhu L, Wang X, Edwards MG, et al. Forkhead box C1 regulates human primary keratinocyte terminal differentiation. PLoS One. 2016; 11:e0167392. https://doi.org/10.1371/journal.pone.0167392.

[32] Zhang T, Yang L, Ke Y, Lei J, Shen S, Shao S, et al. EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation. Cell Death Dis. 2020; 11: 826. https://doi.org/10.1038/s41419-020-03028-1.

[33] Mao Y, Luo W, Zhang L, Wu W, Yuan L, Xu H, et al. STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2017; 37: 920-9. https://doi.org/10.1161/atvbaha.117.309017.

[34] Briso EM, Guinea-Viniegra J, Bakiri L, Rogon Z, Petzelbauer P, Eils R, et al. Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos. Genes Dev. 2013; 27: 1959-73. https://doi.org/10.1101/gad.223339.113.

[35] Xiaohong L, Zhenting Z, Yunjie Y, Wei C, Xiangjin X, Kun X, et al. Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus. J Cell Mol Med. 2022; 26: 2139-51. https://doi.org/10.1111/jcmm.17236.

[36] Robles-Remacho A, Sanchez-Martin RM, Diaz-Mochon JJ. Spatial Transcriptomics: emerging Technologies in Tissue Gene Expression Profiling. Anal Chem. 2023; 95: 15450-60. https://doi.org/10.1021/acs.analchem.3c02029.

[37] Rice G, Rompolas P. Advances in resolving the heterogeneity and dynamics of keratinocyte differentiation. Curr Opin Cell Biol. 2020; 67: 92-8. https://doi.org/10.1016/j.ceb.2020.09.004.

[38] Ishida Y, Kuninaka Y, Nosaka M, Furuta M, Kimura A, Taruya A, et al. CCL2-mediated reversal of impaired skin wound healing in diabetic mice by normalization of neovascularization and collagen accumulation. J Invest Dermatol. 2019; 139: 2517-27.e5. https://doi.org/10.1016/j.jid.2019.05.022.

[39] Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage polarization and diabetic wound healing. Transl Res. 2021; 236: 109-16. https://doi.org/10.1016/j.trsl.2021.05.006.

[40] Yang J, Liu L, Li M, Huang X, Yang H, Li K. Naringenin inhibits pro-inflammatory cytokine production in macrophages through inducing MT1G to suppress the activation of NF-κB. Mol Immunol. 2021; 137: 155-62. https://doi.org/10.1016/j.molimm.2021.07.003.

[41] Mogilenko DA, Shpynov O, Andhey PS, Arthur L, Swain A, Esaulova E, et al. Comprehensive profiling of an aging immune system reveals clonal GZMK(+) CD8(+) T cells as conserved Hallmark of Inflammaging. Immunity. 2021; 54: 99-115.e12. https://doi.org/10.1016/j.immuni.2020.11.005.

[42] Cheng JB, Sedgewick AJ, Finnegan AI, Harirchian P, Lee J, Kwon S, et al. Transcriptional programming of normal and inflamed human epidermis at single-cell resolution. Cell Rep. 2018; 25: 871-83. https://doi.org/10.1016/j.celrep.2018.09.006.

[43] Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (†). Ann Med. 2017; 49: 106-16. https://doi.org/10.1080/07853890.2016.1231932.

[44] Wang J, He J, Zhu M, Han Y, Yang R, Liu H, et al. Cellular heterogeneity and plasticity of skin epithelial cells in wound healing and tumorigenesis. Stem Cell Rev Rep. 2022; 18: 1912-25. https://doi.org/10.1007/s12015-021-10295-8.

[45] Dekoninck S, Blanpain C. Stem cell dynamics, migration and plasticity during wound healing. Nat Cell Biol. 2019; 21: 18-24. https://doi.org/10.1038/s41556-018-0237-6.

[46] Piipponen M, Li D, Landén NX. The immune functions of keratinocytes in skin wound healing. Int J Mol Sci. 2020; 21: 21. https://doi.org/10.3390/ijms21228790.

[47] Provance OK, Geanes ES, Lui AJ, Roy A, Holloran SM, Gunewardena S, et al. Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression. Cancer Lett. 2021; 514: 12-29. https://doi.org/10.1016/j.canlet.2021.05.006.

[48] Qayyum N, Haseeb M, Kim MS, Choi S. Role of Thioredoxin-interacting protein in diseases and its therapeutic outlook. Int J Mol Sci. 2021; 22: 22. https://doi.org/10.3390/ijms22052754.

[49] Li D, Cheng S, Pei Y, Sommar P, Kärner J, Herter EK, et al. Single-cell analysis reveals major histocompatibility complex II-expressing keratinocytes in pressure ulcers with worse healing outcomes. J Invest Dermatol. 2022; 142: 705-16. https://doi.org/10.1016/j.jid.2021.07.176.

[50] Chen YY, Huang SM, Cheng YW, Yen MC, Hsu YL, Lan CE. Investigation of the keratinocyte transcriptome altered in high-glucose environment: an in-vitro model system for precision medicine. J Dermatol Sci. 2023; 109: 37-46. https://doi.org/10.1016/j.jdermsci.2023.01.007.

[51] Zhang Z, Zi Z, Lee EE, Zhao J, Contreras DC, South AP, et al. Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nat Med. 2018; 24: 617-27. https://doi.org/10.1038/s41591-018-0003-0.

[52] Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes. 2001; 50: 1627-35. https://doi.org/10.2337/diabetes.50.7.1627.

[53] Liu Q, Wang H, Wang X, Lu M, Tan X, Peng L, et al. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway. Clin Exp Immunol. 2020; 199: 56-67. https://doi.org/10.1111/cei.13373.

[54] Sidler D, Wu P, Herro R, Claus M, Wolf D, Kawakami Y, et al. TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis. Nat Commun. 2017; 8: 15395. https://doi.org/10.1038/ncomms15395.

[55] Nunomura S, Nanri Y, Ogawa M, Arima K, Mitamura Y, Yoshihara T, et al. Constitutive overexpression of periostin delays wound healing in mouse skin. Wound Repair Regen. 2018; 26: 6-15. https://doi.org/10.1111/wrr.12616.

[56] Taniguchi K, Arima K, Masuoka M, Ohta S, Shiraishi H, Ontsuka K, et al. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop. J Invest Dermatol. 2014; 134: 1295-304. https://doi.org/10.1038/jid.2013.500.

[57] Sawaya AP, Stone RC, Brooks SR, Pastar I, Jozic I, Hasneen K, et al. Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. Nat Commun. 2020; 11: 4678. https://doi.org/10.1038/s41467-020-18276-0.